Published January 14, 2022 | Version v1

EHDEN - D6.3 - Analysis PPP exploitation models

  • 1. SYNAPSE
  • 2. BAYER
  • 3. JANSSEN
  • 4. AstraZeneca
  • 5. Lilly
  • 6. UCB
  • 7. UOXF
  • 8. Odysseus

Description

This deliverable reports on the study of potential exploitation models relevant to public-private partnerships, analysing previous successful and unsuccessful experiences from other IMI projects and beyond. These will serve as starting points and, potentially, one or more “blueprints” for EHDEN sustainability could be devised to guide initial discussions.

The deliverable includes the methodology used, by creating a template fiche to collect information from project participants, as well as the analysis of the completed fiches, which details the key learnings. Lastly, a summary of considerations is extracted as key for EHDEN’s sustainability.

Files

IMI2_EHDEN_D6.3_AnalysisPPPexploitationmodels_final.pdf

Files (616.5 kB)

Name Size
md5:67b3205acc1bb16ee47f81c2e5fc5d0d
616.5 kB Preview Download

Additional details

Funding

European Commission
EHDEN - European Health Data and Evidence Network 806968